Varenicline improves cognitive impairment in a mouse model of mPFC ischemia: The possible roles of inflammation, apoptosis, and synaptic factors

Varenicline improves cognitive impairment in a mouse model of mPFC ischemia: The possible roles of inflammation, apoptosis, and synaptic factors

Ischemia in the medial prefrontal cortex (mPFC) causes cognitive impairment in stroke cases. This study aimed to examine the effects of varenicline as α7 and α4β2 nicotine acetylcholine receptors (nAChRs) agonist, on cognitive impairment, inflammation, apoptosis, and synaptic dysfunction in mPFC isc...

Full description

Bibliographic Details
Main Authors:	Fatemehsadat Seyedaghamiri, Leila Hosseini, Sareh Kazmi, Javad Mahmoudi, Dariush Shanehbandi, Abbas Ebrahimi-Kalan, Reza Rahbarghazi, Saeed Sadigh-Eteghad, Mehdi Farhoudi
Format:	Article
Language:	English
Published:	Elsevier 2022-04-01
Series:	Brain Research Bulletin
Subjects:	Brain ischemia Varenicline Medial prefrontal cortex Memory Anxiety
Online Access:	http://www.sciencedirect.com/science/article/pii/S0361923022000144

Similar Items

Evaluation of Medical Prefrontal Cortex (mPFC) Stimulation and Destruction Effects on Addiction to Morphine
by: Parisa Danesh Motlagh, et al.
Published: (2013-06-01)

Glutamate as a Stressoric Factor for the Ex Vivo Release of Catecholamines from the Rabbit Medial Prefrontal Cortex (mPFC)
by: Bogdan Feliks Kania, et al.
Published: (2021-12-01)

Ex vivo dissection of optogenetically activated mPFC and hippocampal inputs to neurons in the basolateral amygdala: implications for fear and emotional memory
by: Cora eHübner, et al.
Published: (2014-03-01)

Multiple routes of communication within the amygdala-mPFC network: A comparative approach in humans and macaques
by: C. Giacometti, et al.
Published: (2023-01-01)

Positively-valenced stimuli facilitate creative novel metaphoric processes by enhancing medial prefrontal cortical (mPFC) activation
by: Karuna eSubramaniam, et al.
Published: (2013-04-01)

Involvement of DR→mPFC 5-HTergic neural projections in changes of social exploration behaviors caused by adult chronic social isolation in mice
by: Zijian Lv, et al.
Published: (2022-08-01)

Hyper-Activation of mPFC Underlies Specific Traumatic Stress-Induced Sleep–Wake EEG Disturbances
by: Tingting Lou, et al.
Published: (2020-08-01)

High-frequency rTMS modulates emotional behaviors and structural plasticity in layers II/III and V of the mPFC
by: Marco Cambiaghi, et al.
Published: (2022-12-01)

Evaluation of reproductive and renal toxicity of varenicline in male rats
by: Fatih OĞUZ, et al.
Published: (2019-12-01)

Combined chronic blockade of hyper-active L-type calcium channels and NMDA receptors ameliorates HIV-1 associated hyper-excitability of mPFC pyramidal neurons
by: Christina E. Khodr, et al.
Published: (2016-10-01)

Minocycline Attenuates Lipopolysaccharide-Induced Locomotor Deficit and Anxiety-like Behavior and Related Expression of the BDNF/CREB Protein in the Rat Medial Prefrontal Cortex (mPFC)
by: Entesar Yaseen Abdo Qaid, et al.
Published: (2022-11-01)

Electrochemical study of varenicline adsorptive behaviour and its interaction with DNA
by: Radulović Valentina, et al.
Published: (2012-01-01)

Varenicline: A review of the literature and place in therapy
by: Whitley HP, et al.
Published: (2007-06-01)

Varenicline and evaluated outcomes in smoking cessation programmes
by: P. Santus, et al.
Published: (2015-11-01)

Decreased phase information transfer from the mPFC to the BLA: During exploratory behavior in CUMS rats
by: Qingying Cao, et al.
Published: (2023-03-01)

A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
by: Ali Ramazan Benli, et al.
Published: (2017-02-01)

Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation
by: S. R. Gilyarevskiy
Published: (2019-03-01)

Effects of Duloxetine Treatment on Cognitive Flexibility and BDNF Expression in the mPFC of Adult Male Mice Exposed to Social Stress during Adolescence
by: Hang Xu, et al.
Published: (2016-10-01)

Effect of MDR C3435T polymorphism on Varenicline treatment in quit smoking
by: Nurgul Bozkurt, et al.

Varenicline-induced sucidal behavior: Case report and literature review
by: T. Gutierrez Higueras, et al.
Published: (2022-06-01)

Varenicline treatment for smoking cessation in high risk patients: a budget impact analysis
by: Federico Spandonaro, et al.
Published: (2017-10-01)

Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study
by: Carlos A. Jiménez-Ruiz, et al.
Published: (2017-12-01)

Spectroscopic strategies for quantitation of varenicline in pharmaceutical preparations and content uniformity testing
by: Fawzia Ibrahim, et al.
Published: (2022-09-01)

Combination of behavioral therapy and varenicline for smoking cessation: Time to beat nicotine
by: Avnica Agarwal, et al.
Published: (2022-01-01)

Drug-induced liver injury due to varenicline: a case report
by: Sprague David, et al.
Published: (2012-06-01)

A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
by: Baker CL, et al.
Published: (2018-01-01)

Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence
by: Burke MV, et al.
Published: (2016-04-01)

VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY?
by: Yu. V. Lukina, et al.
Published: (2015-09-01)

Manic episode associated with Varenicline treatment in a patient with a history of depression (eng)
by: Pınar Kızılay Çankaya, et al.
Published: (2020-04-01)

Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
by: Saeed Ahmed, et al.
Published: (2018-09-01)

Increased Inhibition of the Amygdala by the mPFC may Reflect a Resilience Factor in Post-traumatic Stress Disorder: A Resting-State fMRI Granger Causality Analysis
by: Feng Chen, et al.
Published: (2018-10-01)

Nicotine dependence and neuropsychotic effects of varenicline
by: T. M. Bukatina, et al.
Published: (2018-03-01)

The efficacy and safety of varenicline nasal spray for the management of dry eye signs: a systematic review and meta-analysis
by: Bader Bashrahil, et al.
Published: (2023-07-01)

Modulating the Activity of MPFC With tDCS Alters Endowment Effect
by: Wenmin Guo, et al.
Published: (2019-09-01)

Multimodal treatment for smoking cessation with varenicline in alcoholic, methadone-maintained, and psychotic patients: A one-year follow-up
by: Antonia Raich, et al.
Published: (2018-12-01)

Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study
by: Christina Gratziou, et al.
Published: (2012-02-01)

Characteristics of first-time varenicline users – A cross-sectional study in Finnish quitters
by: Hanna E. Tervonen, et al.
Published: (2017-04-01)

CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
by: Juliana Rocha Santos, et al.
Published: (2015-02-01)

An integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy
by: Kacper Więcław, et al.
Published: (2023-08-01)

Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial
by: Mengling Deng, et al.
Published: (2023-05-01)